Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.54 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.54 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.54 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.51 |
| ▸ | TLR2 | O60603 | 2/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.47 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.47 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
| ▸ | RRM1 | P23921 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL367556 | 1.00 | GNAI3 (0.54) | GNAI3GNAO1GNAI1NOD1TLR2 | |
| SCHEMBL10613585 | 0.98 | GNAI3 (0.56) | GNAI3GNAO1GNAI1NOD1TLR2 | |
| SCHEMBL10609973 | 0.98 | GNAI3 (0.56) | GNAI3GNAO1GNAI1NOD1TLR2 | |
| SCHEMBL10612555 | 0.98 | GNAI3 (0.56) | GNAI3GNAO1GNAI1NOD1TLR2 | |
| SCHEMBL10614116 | 0.98 | GNAI3 (0.56) | GNAI3GNAO1GNAI1NOD1TLR2 | |
| SCHEMBL10611883 | 0.98 | GNAI3 (0.56) | GNAI3GNAO1GNAI1NOD1TLR2 | |
| SCHEMBL5267100 | 0.98 | GNAI3 (0.56) | GNAI3GNAO1GNAI1NOD1TLR2 | |
| SCHEMBL7771135 | 0.98 | GNAI3 (0.56) | GNAI3GNAO1GNAI1NOD1TLR2 | |
| SCHEMBL10611658 | 0.98 | GNAI3 (0.56) | GNAI3GNAO1GNAI1NOD1TLR2 | |
| SCHEMBL22956 | 0.98 | GNAI3 (0.56) | GNAI3GNAO1GNAI1NOD1TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-20140288142-A1 | NITRIC OXIDE DONOR COMPOUNDS | NICOX SA (FR) | 2014-09-25 | — | — | US | disclosed |
| US-20040030093-A1 | Metal catalyst for ring-opening polymerization of heterocyclic compound | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1340780-A1 | METAL CATALYST FOR RING-OPENING POLYMERIZATION OF HETEROCYCLIC COMPOUND | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-09-03 | — | — | EP | disclosed |
| EP-0162747-B1 | LYSINE ESTERS USED AS ABSORPTION ENHANCING AGENTS | MERCK & CO. INC. (US) | 1988-12-07 | — | — | EP | disclosed |
| US-4749694-A | ENHANCING AGENTS FOR GASTROINTESTINALLY AND RECTALLY ADMINISTEAED DRUGS | MERCK & CO., INC. (US) | 1988-06-07 | — | — | US | disclosed |
| EP-0162747-A1 | Lysine esters used as absorption enhancing agents | MERCK & CO. INC. (US) | 1985-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288142-A1 | NITRIC OXIDE DONOR COMPOUNDS | NOS3, NOS2, NOS1 | GNAI3 769/4885GNAO1 381/4885GNAI1 821/4885 |
| US-20040030093-A1 | Metal catalyst for ring-opening polymerization of heterocyclic compound | MAX, PCNA, POLM | GNAI3 4693/4885GNAO1 4321/4885GNAI1 4738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.